Correction to: The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children

Correction to: Trials 22, 56 (2021)

https://doi.org/10.1186/s13063-020-04953-4

Following publication of the original article [1], we were notified that the originally published Table 2 was incorrect. References 1–33 were not impacted by the table update and remain unchanged, but are updated from reference 34 onward.

• Originally published Table 2

Table 2 NYCKidSeq participant outcomes by survey timepoint

• Corrected Table 2

Table 2 NYCKidSeq participant outcomes by survey timepoint

REFERENCES:

34. Read CY, Perry DJ, Duffy ME. Design and psychometric evaluation of the Psychological Adaptation to Genetic Information Scale. J Nurs Scholarsh. 2005;37(3):203–8.

35. Kohler JN, Turbitt E, Lewis KL, Wilfond BS, Jamal L, Peay HL, et al. Defining personal utility in genomics: A Delphi study. Clin Genet. 2017 Sep;92(3):290–7.

36. Mazor KM, Street RL Jr, Sue VM, Williams AE, Rabin BA, Arora NK. Assessing patients’ experiences with communication across the cancer care continuum. Patient Educ Couns. 2016 Aug;99(8):1343–8.

37. Street RL Jr, Mazor KM, Arora NK. Assessing Patient-Centered Communication in Cancer Care: Measures for Surveillance of Communication Outcomes. J Oncol Pract. 2016 Dec;12(12):1198–202.

38. Lobb EA, Butow PN, Moore A, Barratt A, Tucker K, Gaff C, et al. Development of a communication aid to facilitate risk communication in consultations with unaffected women from high risk breast cancer families: a pilot study. J Genet Couns. 2006;15:393–405.

39. Sanderson SC, Suckiel SA, Zweig M, Bottinger EP, Jabs EW, Richardson LD. Development and preliminary evaluation of an online educational video about whole-genome sequencing for research participants, patients, and the general public. Genet Med. 2016;18:501–12.

40. Li M, Bennette CS, Amendola LM, Ragan Hart M, Heagerty P, Comstock B, et al. The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation. J Genet Couns. 2019 Apr;28(2):477–90.

41. Biesecker BB, Woolford SW, Klein WMP, Brothers KB, Umstead KL, Lewis KL, et al. PUGS: A novel scale to assess perceptions of uncertainties in genome sequencing. Clin Genet. 2017 Aug;92(2):172–9.

42. Brehaut JC, O’Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, et al. Validation of a decision regret scale. Med Decis Making. 2003 Jul;23(4):281–92.

43. Agency for Healthcare Research and Quality (AHRQ). Medicare Expenditure Panel Survey (MEPS)-Household Component (HC), Access to Care Section (P18R5/P19R3/P20R1), Variable: Recommended Family Testing & Monitoring. US Department of Health and Human Services.

44. Varni JW, Seid M, Kurtin PS. PedsQL^TM 4.0: Reliability and Validity of the Pediatric Quality of Life Inventory^TM Version 4.0 Generic Core Scales in Healthy and Patient Populations. Med Care. 2001 Aug;39(8):800.

45. Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D [Internet]. Quality of Life Research. 2010. p. 875–86. Available from: https://doi.org/10.1007/s11136-010-9648-y

46. Hebert PL, Sisk JE, Wang JJ, Tuzzio L, Casabianca JM, Chassin MR, et al. Cost-effectiveness of nurse-led disease management for heart failure in an ethnically diverse urban community. Ann Intern Med. 2008;149:540–8.

47. Hoefman RJ, Van Exel NJA, Brouwer WBF. iMTA Valuation of Informal Care Questionnaire (iVICQ). Version 1.0 (December 2011). Rotterdam: iBMG / iMTA, 2011. [retrieved from www.bmg.eur.nl/english/imta/publications/manuals_questionnaires/ on 01/12/2021]

48. Haun, J., Noland Dodd, V. J., Graham-Pole, J., Rienzo, B., & Donaldson, P. (2009). Testing a Health Literacy Screening Tool: Implications for Utilization of a BRIEF Health Literacy Indicator. Federal Practitioner, 26(12), 24-31.

49. McNaughton CD, Cavanaugh KL, Kripalani S, Rothman RL, Wallston KA. Validation of a Short, 3-Item Version of the Subjective Numeracy Scale [Internet]. Vol. 35, Medical Decision Making. 2015. p. 932–6. Available from: https://doi.org/10.1177/0272989x15581800

50. Horowitz CR, Abul-Husn NS, Ellis S, Ramos MA, Negron R, Suprun M, et al. Determining the effects and challenges of incorporating genetic testing into primary care management of hypertensive patients with African ancestry. Contemp Clin Trials. 2016 Mar;47:101–8.

51. Shea JA, Micco E, Dean LT, McMurphy S, Sanford Schwartz J, Armstrong K. Development of a Revised Health Care System Distrust Scale [Internet]. Vol. 23, Journal of General Internal Medicine. 2008. p. 727–32. Available from: https://doi.org/10.1007/s11606-008-0575-3

52. United States Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES), 1999-2000 [Internet]. ICPSR Data Holdings. 2009. Available from: https://doi.org/10.3886/icpsr25501.v3

53. The GenIUSS Group. Best Practices for Asking Questions to Identify Transgender and Other Gender Minority Respondents on Population- Based Surveys. Los Angeles, CA: The Williams Institute, 2014.

54. Jones NA. Update on the U.S. Census Bureau’s Race and Ethic Research for the 2020 Census. Survey News 2015;3(5). (https://www.census.gov/content/ dam/Census/newsroom/press-kits/2014/article_race_ethnic_research_2020census_jones.pdf)

55. Matthews K, Phelan J, Jones NA, Konya S, Marks R, Pratt BM, et al. 2015 national content test race and ethnicity analysis report: A new design for the 21st century. US Census Bureau Washington, DC; 2017.

56. Goddard KAB, Angelo FAN, Ackerman SL, Berg JS, Biesecker BB, Danila MI, et al. Lessons learned about harmonizing survey measures for the CSER consortium. Journal of Clinical and Translational Science. Cambridge University Press; 2020;4:537–46.

The original article has been corrected.